Alberta (ASCC)

Group Photo Of Professional Colleagues Working Together In Clinical Analysis Laboratory
Clinical Chemist Working
Clinical Chemist Group
Clinical Chemist in Lab
Clinical Chemist in Lab
Clinical Chemist Group
Clinical Chemist Working on Computer
Clinical Chemist in Lab

Alberta 3

 

ASCC President’s Message

It is truly an honor to serve as president of the ASCC. Located East of the Rockies and West of the rest, our society is filled with talented and hard-working members who make oversized contributions to clinical biochemistry. At our recent annual general meeting celebrating the 50th anniversary of the founding the ASCC, we featured a keynote presentation by Nobel laureate and University Alberta Professor Sir Michael Houghton as well as history making achievements and science by Alberta luminaries Drs. David Kinniburgh, Todd Anderson and George Cembrowski.

In the coming year, I will be working closely with ASCC and CSCC councils on issues of professional recognition for clinical biochemists.  As CSCC councillor and Board Chair of the Alberta Association of Clinical Laboratory Doctoral Scientists, I am well positioned to contribute to both provincial and national efforts to realize a brighter future for Clinical Biochemists. Also in March, ASCC will host a virtual presentation by the CSCC travelling lecturer, Dr. Sophie Gosselin, and in October we will have our AGM in Calgary.

I would like to thank Dr. Alex Chin, who served as President from 2020-2021, as well as Drs. Miranda Brun (Treasurer: 2021- ) and Josh Raizman (Secretary: 2018-2022) for their diligent efforts over the last few years. All helped bring us to where we are today. And while I’d like to especially thank Josh for his long and generous service with ASCC, I would also like to take this opportunity to welcome our new Secretary Dr. Ola Ismail!

Finally, to our members: thank you for placing confidence in me. Please feel free to share your thoughts and ideas to ASCC executive over the coming year (ascc.executive@gmail.com).

Best regards,

Lawrence de Koning, PhD DABCC FAACC FCACB
President, ASCC 2023

2023 ASCC Annual General Meeting

For details and registration see below

Lawrence

ASCC Council

Lawrence

PRESIDENT

2022 – 2024

Dr. Lawrence de Koning

Ola

SECRETARY

2023 – 2025

Dr. Ola Ismail

 

Miranda

TREASURER

2021 – 2024

Dr. Miranda Brun

Past ASCC Council

Year President Secretary Treasurer Member At Large
2023 Lawrence de Koning Ola Ismail Miranda Brun
2022 Lawrence de Koning Lawrence de Koning
& Josh Raizman*
Miranda Brun
2021 Alex Chin Josh Raizman &
Lawrence de Koning*
Miranda Brun
2020 Alex Chin Josh Raizman Albert Tsui
2019 Jessica Boyd Josh Raizman Albert Tsui
2018 Jessica Boyd Josh Raizman Albert Tsui
2017 Allison Venner Jessica Boyd Karina Capote
2016 Allison Venner Jessica Boyd Karina Capote
2015 Richard Krause Allison Venner Karina Capote
2014 Richard Krause Allison Venner Kareena Schnabl
2013 Val Dias Allison Venner Kareena Schnabl
2012 ASCC activities suspended
2011 ASCC activities suspended
2010 Fiona Bamforth Annu Khajuria
2009 Fiona Bamforth Annu Khajuria Trefor Higgins
2008 Fiona Bamforth Annu Khajuria Trefor Higgins
2007 Fiona Bamforth Don LeGatt Trefor Higgins
2006 Fiona Bamforth Don LeGatt Trefor Higgins
2005 Andrew Lyon Don LeGatt Trefor Higgins
2004 Andrew Lyon Don LeGatt Trefor Higgins Position Abolished in Bylaw revision
2003 Richard Krause Andrew Lyon Trefor Higgins Les Sackney
2002 Richard Krause Andrew Lyon Trefor Higgins Les Sackney
2001 Richard Krause Andrew Lyon Trefor Higgins Les Sackney
2000 George Blakney Luella Yakymyshyn Trefor Higgins Les Sackney
1999 George Blakney Luella Yakymyshyn Trefor Higgins
1998 George Blakney Ellen Janzen Trefor Higgins
1997 George Blakney Arlene Crowe Trefor Higgins
1996 Connie Prosser Arlene Crowe Trefor Higgins Val Dias
1995 Connie Prosser Arlene Crowe Trefor Higgins Robert Stinson
1994 Randy Yatscoff Arlene Crowe Trefor Higgins Jim Wesenberg
1993 Randy Yatscoff Yu Wah Wong Jim Wesenberg
1992 George Blakney Trefor Higgins Anand Swaroop Tom Csorba
1991 George Blakney Don  Shipp Anand Swaroop Maria Tesanovic
1990 Richard Krause Fred Jajczay Anand Swaroop Maria Tesanovic
1989 Richard Krause Fred Jajczay Anand Swaroop Ed Piotrkowski
1988 David Kinniburgh Fred Jajczay Anand Swaroop Ed Piotrkowski
1987 David Kinniburgh Don LeGatt Les Sackney Paul Kean
1986 Trefor Higgins Don LeGatt Les Sackney Anand Swaroop
1985 Trefor Higgins Don LeGatt Les Sackney Maria Tesanovic
1984 James Wesenberg Luella Yakymyshyn Rick Goulet Trefor Higgins
1983 James Wesenberg Luella Yakymyshyn Rick Goulet
1982 Robert Baynton Peter Krahn Richard Krause Mark Salkie
1981 Robert Baynton Peter Krahn Richard Krause Robert Stinson
1980 Allison Dinwoodie Peter Krahn Richard Krause Robert Stinson
1979 Allison Dinwoodie Peter Krahn Peter Krahn Robert Baynton
1978 Jim Russell Jim Russell
1977 Richard Krause Jim Russell
1976 Fred Jajczay Jim Russell
1975 Fred Jajczay Keith Todd Keith Todd
1974 R.W.Bide Keith Todd Keith Todd
1973 Council: A.Swaroop, J.D.Taylor, R.Baynton, R.Bide
1972 Council: A.Swaroop, J.D.Taylor, R.Baynton, R.Bide

ASCC By-Laws

ASCC By-Laws 2016 PDF

ARTICLE 1 GENERAL
i) Clinical chemistry/biochemistry shall be defined as the application of chemical
principles and techniques to the detection, treatment and study of disease
states.
ii) The Alberta Society of Clinical Chemists herein referred to as the “Society” shall
be the name of the Society.
iii) The objectives of the Society and its territories of operation shall be as stated
in the Letters Patent:
a) To promote high professional standards among clinical biochemists.
b) To encourage and advance clinical biochemistry.
c) To elevate the standard of practice of clinical biochemistry in order to render
efficient service to the public.
d) To promote sound employee-employer relationships and relations with
affiliated groups and related professions.
e) To represent officially, in policy and practice, clinical biochemistry within the
Province of Alberta.
f) To support continuing medical education and post graduate training in clinical
biochemistry within the province of Alberta
iv) Members of the Society shall subscribe to its Constitution and By-Laws, and
shall be subject to the duties, obligations, rights and privileges contained
therein.
v) The Head Office of the Society shall be situated at the last known address of
an Executive Member or at such place as may from time to time be
established by an extraordinary resolution approved by a two-thirds majority
vote at an Annual General Meeting.
vi) The Society shall be constituted as a provincial section of the Canadian Society of
Clinical Chemists and its operation shall be subject to the Canadian Society of
Clinical Chemists By-Laws.

ARTICLE 2 MEMBERSHIP
Qualification
i) The Society shall consist of Full Members, Affiliate Members, Honorary
Members and Emeritus Members residing within the province of Alberta. An
Emeritus Member that practiced within Alberta and was a Society member
may remain as a member if they move outside of the province.
ii) A person is eligible for Full Membership who has graduated from a University
program approved by the Society with a Masters Degree or Doctoral Degree*,
or equivalent, and who is engaged in professional activity in Clinical
Biochemistry.
*Doctoral Degree includes: PhD, DSc, MD, MB, ChB, DVM or equivalent.
iii) Both Full and Associate Members of the Canadian Society of Clinical Chemists
residing in the province of Alberta, shall be Full Members of the Alberta Society of
Clinical Chemists
iv) Honorary Members and Emeritus Members of the Canadian Society of Clinical
Chemists residing within the province of Alberta shall be Honorary or Emeritus
members, respectfully, of the Alberta Society of Clinical Chemists.
v) A person who has made an outstanding contribution to clinical biochemistry
may upon being nominated by two Full Members, and following
recommendation of the executive be elected by the membership as an
Honorary Member.
vi) Any person who does not qualify as a Full Member, Emeritus Member or
Honorary Member may become an Affiliate Member of the Society after being
nominated in writing and having the said nomination approved by the
Executive.
vii) Applicants for membership shall be sponsored by two Full Members who have
professional knowledge of the applicant, or in the case of absolute unavailability
of such Full Members, by persons of attestable reputation who, on the basis of
personal knowledge, and upon request can submit a professional and
character appraisal of the applicant.
viii) Full Members and Affiliate Members of the Society shall pay to the Treasurer
such annual dues as may be recommended by the Executive and levied
following approval by a two-thirds majority vote at an Annual General Meeting,
or by a postal/telephonic/electronic vote, following recommendation by the
Executive. The Canadian Society of Clinical Chemists may collect annual dues
on behalf of the Alberta Society of Clinical Chemists for members who are also
members of the Canadian Society of Clinical Chemists.

Termination
ix) Any member may resign from the Society by lodging a letter stating such
intent with the Secretary.
x) A member or Affiliates’ name shall be deleted from the Membership Register
if dues are more than twelve months in arrears.
xi) Notwithstanding the provision of Section x, the Executive may, for cause
deemed sufficient, defer such payment of dues, with the member remaining in
arrears.
xii) Any person who has ceased to be a member for non-payment of dues may,
upon payment of a reinstatement fee, such as may be determined by the
Executive, and all or part of the arrears, apply for re-admission to the Society.
xiii) After a membership lapse of more than one year, for any reason whatsoever,
such person shall apply as a new member through the usual procedure.
xiv) The Executive shall have the right and privilege to terminate the membership
of any member found to have been in breach of professional ethics. Such
termination shall take place only after a member has been given opportunity
to appear at a hearing or be represented. Such hearing shall be conducted by
the President or his delegate and two other unbiased Full Members. The
member shall have the right to appeal termination to the Executive of the
Society.

Rights & Privileges
xv) Full Members shall have all rights and privileges granted to members, shall
have the rights to nominate, to vote in elections and upon matters pertaining
to the Society affairs, to hold elected office, to chair standing or ad hoc
committees of the Society and receive all mailings of the society.
xvi) Honorary Members shall have all the rights and privileges accorded to Full
Members except that they shall not hold elected office or chair committees
appointed by the Executive.
xvii) Affiliate Members shall have all the rights and privileges accorded to Full
Members, except that they shall not vote, hold elected office or chair
committees appointed by the Executive.
xviii) Emeritus Members shall have all the rights and privileges accorded to Full
Members.

Remuneration
xix) No member of the Society or the Executive shall receive any remuneration for
their services. Members may be reimbursed out of the Society Treasury for all
such costs, charges and expenses sustained or incurred in, or about or in
direct relation to the affairs or the Society, except such costs, charges, or
expenses as are occasioned by default or willful neglect.
Liability
xx) No member of the Society shall in his individual capacity, be liable for any
debt or liability of the Society.

ARTICLE 3 ORGANIZATION
A. Government
i) The rules contained in “Roberts Rules of Order, Revised” shall govern the
proceedings of the Society in all situations in which they are applicable, and
in which they are not inconsistent with the Societies Act, or the By-Laws of
the Society, or the standing rules of the Society.
ii) The governing body of the Society, known and referred to as the Executive,
shall consist of three (3) members:
a) a President who shall serve for a term of two years
b) a Secretary who shall serve for a term of two years
c) a Treasurer who shall serve for a term of two years
Normally the President, Secretary and Treasurer shall not be replaced in the
same year. Any two members shall constitute a quorum at meetings of the
Executive.
iii) The Executive shall be charged with the duty of conducting the business,
discipline and management of the Society and its affairs, and may exercise all
such powers of the Society as are not required by the Societies Act or by
these By-Laws to be exercised by the membership at a General meeting or as
specifically provided.
iv) The Society Executive shall act as By-Laws, Membership, and Meetings
Committees, and shall normally deal with all committee reports.
v) The Executive shall appoint such Standing Committees, from time to time, as
may be required. The Executive may also appoint such ad hoc or Special
Committees as may be required to conduct the business or implement the
objectives of the Society.
vi) The President of any Committee shall render to the Executive, at the request
of the Executive, a written report of the Committees activities. All such reports
shall be subject to the approval of the Executive. A report containing a
recommendation shall be the subject of a motion by a member of the
Executive
vii) The Executive may, and is hereby authorized to borrow money upon the
credit of the Society, limit or increase the amount to be borrowed, issue
debentures or other securities for such sums and at such prices as may be
deemed fair and expedient, and mortgage hypothecate, charge or pledge all or
any of the real and private property, and rights and undertakings of the
Society to secure any such debentures or other securities or any money
borrowed or any other liability of the Society.
viii) The funds and property of the Society shall be used and dealt with for
legitimate objectives only, and in accordance with the By-Laws.
ix) The Executive must be Full Members in good standing with the Canadian
Society of Clinical Chemists.
B. President
i) The President shall preside at all meetings of the Society and at the Executive
and shall be an ex-officio member of all committees, except the Committee on
Nominations, and shall in general represent the Society, declaring its will, and
in all things promote the objectives of the Society.
ii) In the absence or inability of the President to preside at any meeting, the
President shall designate another member of the Executive to preside there
at.
iii) The President shall authenticate, by signature when necessary, all the acts
proceedings of the Society.
iv) The President may call meetings of the Executive, as required, to conduct the
affairs of the Society.
v) The President may invite non-voting observers or appointees to be present at
any or all of the deliberations of the Executive, such observers or appointees
having no speaking privileges except by resolution of the Executive.
C. Secretary
i) It shall be the duty of the Secretary to attend all meetings of the Society and
of the Executive, and to keep accurate minutes of the proceedings at such
meetings. The Secretary further shall have charge of the Society Seal, which
seal, whenever used shall be authenticated by the signature of the Secretary
and the President. The Secretary shall send to the membership
announcements of all general meetings, including a detailed agenda, attend
to correspondence and perform such other duties as ordinarily pertain to that
office. The Secretary shall be under the direction of the Executive and
President.
ii) The Secretary shall receive and process all applications for membership or
changes in membership status and shall propose lists of new members and
changes in membership status to the Executive for approval.
iii) The Secretary shall also keep a record of all the members of the Society and
their last known contact information.
D. Treasurer
i) The Treasurer shall collect and receive all annual membership dues and other
assessments as may be levied by the Society.
ii) The Treasurer shall be charged with the general supervision of all the funds of
the Society, record all monetary receipts and disbursements and prepare a
complete financial statement for submission to the Annual General Meeting.
iii) All disbursements of Society funds shall be made by the Treasurer, and
another member of the Executive when appropriate, at the President’s
discretion.
iv) The books, accounts and records of the Treasurer shall be audited at least
once each year by a duly qualified accountant or by two members of the
Society appointed for that purpose by the membership at the Annual General
Meeting or by the Executive at an Executive Meeting. A complete and proper
auditor’s report on the standing of the books for the previous year shall be
submitted by such auditor at the Annual Meeting of the Society.
v) The fiscal year of the Society shall correspond to the calendar year ending the
31st December of each year.

ARTICLE 4 MEETINGS AND ELECTIONS
i) The Society shall hold an Annual General Meeting on or before the 31st day of
December in each year at a place to be determined by the Executive.
ii) A Nominations Committee, consisting of President and two members, shall
be elected to serve for a one (1) year term, by the membership at the Annual
Meeting. The Nominations Committee shall be responsible to accept and
present nominations for such vacancies as may, from time to time, occur on
the Executive.
iii) Members shall be elected to fill such positions on the Executive, as have
become vacant, at the Annual General Meeting. The members of the Executive
so elected shall serve until their successors are elected and installed. Any
vacancy on the Executive occurring during the year shall be filled at the next
meeting of the Executive as provided herein.
iv) One quarter of the voting members in good standing shall constitute a quorum
at any meeting.
v) Meetings of the Society may be called at any time by the Secretary upon the
instructions of the President or the Executive dated twenty days prior to such
meeting.
vi) A special meeting shall be called by the President or Secretary upon receipt of
a petition signed by one-quarter of the voting members in good standing,
setting forth the reasons for calling such meeting.

ARTICLE 5 BY-LAWS
i) The By-Laws of the Society may be rescinded, altered or added to by a
“Special Resolution” passed by a majority of not less than three-fourths of
such members entitled to vote as are present in person, by telephone or by
electronic communication, at a membership meeting of which one month’s written
notice specifying the intention to propose the resolution as a special resolution
has been duly given.

ARTICLE 6
i) Adoption of these By-laws shall not result in change of membership status for
any member of the Society.

2023 ASCC Annual General Meeting

Alberta 3

2023 ASCC Annual General Meeting

Friday October 13, 2023

Primary Site (Calgary): 3535 Research Rd NW, Calgary AB T2L 2K8, Theatre Room, Main Floor
Secondary Site (Edmonton): University of Alberta, ECHA, Room 1-490
Virtual: Zoom link will be provided to those who registered

Digitization, Accessibility, and
Data Science in Lab Testing

REGISTRATION FORM

All Times: Mountain Time (MT)

FRIDAY, OCTOBER 13, 2023
1300-1355  ASCC Business Meeting (ASCC Members ONLY)
1355-1400 Welcome and ASCC Outstanding Contribution to Clinical Chemistry Award
1400-1500 Keynote Speaker:
Dr. Nitika Pai, Department of Medicine at McGill University, Centre for Outcomes Research & Evaluation, Montreal, Quebec, Canada
2023 CSCC Travelling Lecturer, Sponsored by Biorad
Quoi de Neuf?  Diagnostic technologies and digital solutions for transformation and impact

At the conclusion of this session, participants will be able to:

  1. Identify Novel Diagnostic (Dx) Technologies
  2. Understand the evidence on connected global Dx solutions
  3. Appreciate the solutions with potential for digital health transformation and their impact on patient centered outcomes
1500-1510  Break
1510-1600 Dr. Dennis Orton, University of Calgary, Cumming School of Medicine, Alberta Precision Labs, Calgary Alberta Canada
WoRking smart, not haRd, MoRe examples of R in the clinical lab

At the conclusion of this session, participants will be able to:

  1. Understand how R may be used to perform reproducible large-scale data analyses
  2. Appreciate how using R will complement other analytics tools
  3. Gain some appreciation about how the R language has evolved over time to become more user-friendly
1600-1615  Past Trainee Presentation #1: Dr. Michael Reid, Clinical Chemist at DynaLIFE Medical Labs, Calgary, Alberta, Canada
Vanishing Act: Air Exposure During Neonatal Blood Collection Significantly Reduces Total Plasma Carbon Dioxide

At the conclusion of this session, participants will be able to:

  1. Describe the components of the whole testing process that affect the stability of TCO2 and what factors result in the greatest loss of TCO2.
  2. Implement strategies to reduce the loss of TCO2 in neonatal blood collections that are exposed to air
1615-1630 Current Trainee Presentation #1: Dr. Sally Ezra, Senior Clinical Biochemistry Postdoctoral Fellow, University of Calgary and Alberta Precision Laboratories, Calgary, Alberta, Canada
Development of LC-MS/MS Panel for Accurate Diagnosis of Primary Aldosteronism

At the conclusion of this session, participants will be able to:

  1. Describe the pathophysiology of Primary Aldosteronism (PA).
  2. Understand the challenges associated with current immunoassays in the diagnosis PA.
  3. Recognize the motivation behind developing an LC-MS/MS panel for PA diagnosis.

 

1630-1645 Current Trainee Presentation #2: Dr. Fahed Elian, Junior Clinical Biochemistry Postdoctoral Fellow, University of Alberta and Alberta Precision Laboratories, Edmonton, Alberta, Canada
What the HIL is happening! Evaluation of hemolysis, Icterus, and lipemia indices for specimen integrity

At the conclusion of this session, participants will be able to:

  1. Understand how hemolysis, icterus, and lipemia can interfere with clinical chemistry tests
  2. Describe how HIL indices can be used to detect interferences and impact specimen handling and reporting across chemistry platforms

 

1645 – 1700 Closing Remarks

*This event is an accredited group learning activity as defined by the CSCC/CACB professional development program.

REGISTRATION

  • Registration is required to attend the event (no cost)
  • Please register by Thursday October 5, 2023 using the Google form
  • Please note: Only ASCC members can attend the ASCC business meeting.  If ASCC dues are not paid through CSCC, a membership fee ($10) must be paid before the meeting.
  • For any questions or concerns, please email ascc.executive@gmail.com

2022 ASCC Annual General Meeting

2022 ASCC Annual General Meeting

October 14-15, 2022
Forest Park Hotel (formerly Sawridge Inn), Jasper AB

Masking policy: masks are optional but highly recommended

Celebrating history-making science in Alberta:
The 50th Anniversary of the ASCC

REGISTRATION FORM

All Times: Mountain Time (MT)

FRIDAY 14 OCTOBER 2022 (Executive Suite Room 380)
9:00-11:00 pm  Opening drop-in Mixer
SATURDAY 15 OCTOBER 2022 (Sawridge Ballroom in lower level)
7:00-7:55 am Registration and Breakfast
7:55-8:00 am Welcome & Land Acknowledgement 
8:00-9:00 am Keynote Speaker:
Sir Michael Houghton, 2020 Nobel Laureate in Medicine, Director & Professor, Li Ka Shing Applied Virology Institute, Faculty of Medicine & Dentistry, University of Alberta
Eliminating hepatitis C as a major public health threat (virtual presentation)
At the conclusion of this presentation, participates will be able to:
1. Describe important virus discovery methods.
2. Understand Hepatitis C Virus Diagnostic test development (EIA & NAT).
3. Describe HCV vaccine discovery and the path forward to obtaining regulatory approval.
9:00-9:40 am Dr. Dave Kinniburgh, Director, Alberta Centre for Toxicology; Clinical Professor, Department of Laboratory Medicine and Pathology, University of Alberta; Adjunct Associate Professor, Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary 
50 years with the ASCC – a personal perspective
At the conclusion of this presentation, participants will be able to:
1. Appreciate the significant advances in clinical chemistry over the past 50 years.
2. Recognize the increased role of clinical chemists over the past 50 years.
9:40-9:55 am Trainee Presentation #1: Dr. Sally Ezra, Junior Clinical Biochemistry Post-doctoral Fellow, University of Calgary and Alberta Precision Laboratories
Can we transfer Insulin-Like Growth Factor 1 Reference Interval between Mass Spectrometry Assays with different Traceability?
At the conclusion of this presentation, participates will be able to:
1. Describe the pathophysiology of insulin-like growth factor 1 (IGF-1).
2. Discuss the pitfalls in IGF-1 measurements.
3. Explain how the agreement between two LC-MS/MS assays with different traceability enables the transference of IGF-1 Reference interval.
9:55-10:10 am Trainee Presentation #2: Dr. Michael Reid, Senior Clinical Biochemistry Post-doctoral Fellow, University of Calgary and Alberta Precision Laboratories
Evaluation of the stability of fecal immunochemical test specimens
At the conclusion of this presentation, participants will be able to:
1. Describe the utility of FIT screening programs.
2. Understand the importance of performing internal evaluations of FIT specimen stability.
3. Describe strategies to reduce the rate of false negative FIT results.
10:10-10:30 am Coffee and snack break
10:30-11:30 am Dr. Todd Anderson, Dean and Professor, Cumming School of Medicine, Department of Cardiac Sciences, University of Calgary
Canadian Cardiovascular Society (CCS) Dyslipidemia guidelines: History and current recommendations (virtual presentation)
At the conclusion of this presentation, participants will be able to:
1. Understand the Canadian Cardiovascular Society dyslipidemia guidelines history and process.
2. Understand the role of the laboratory in risk assessment and treatment.
3. Recognize novel aspects of the 2021 guidelines.
11:30 am-12:30 pm Dr. George Cembrowski, Professor, Department of Laboratory Medicine and Pathology, University of Alberta
Using big data to demonstrate inferiority/superiority (not equivalent) of comparative analytical methodologies
At the conclusion of this presentation, participants will be able to:
1. Understand that virtually all blood tests demonstrate diurnal variation.
2. Understand that for certain analytes, within day variation can exceed between day variation.
3. Understand the average of deltas patient-based quality control.
4. Understand that most non-hospitalists are clueless when interpreting within day test variation.
5. Be aware of the future informatics needs in the clinical laboratory.
12:30-5:00 pm Afternoon on your own
 5:00-5:45 pm AACC Business Meeting (ASCC members only)
 5:00-6:45 pm Vendor Exhibit Viewing (open bar 5:45-6:45 pm)
6:30-8:00 pm Dinner buffet & presentation of the ASCC Outstanding Contribution to Clinical Biochemistry Award
After-Dinner Speaker: Dr Greg Sivakoff, Associate Professor, Department of Physics, University of Alberta 
 New Golden Eyes for the Infrared Skies
The recently launched and commissioned NASA’s James Webb Space Telescope is poised to transform our understanding of the near-infrared skies, and with it our understanding of the Universe. I’ll discuss some of the key questions that Canadian and international astronomers hope to answer, on topics from stellar birth to stellar death, from our own solar system to the distant (early) Universe, and from planets to supermassive black holes.
9:00-11:00 pm After Dinner Mixer (Executive Suite, Room 380)

 

This event is an Accredited Group Learning Activity as defined by the CSCC/CACB Professional Development Program

Past ASCC Annual General Meeting